Details of the Drug
General Information of Drug (ID: DM3Q1HL)
| Drug Name |
T-3.5
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Hemozoin formation inhibitors (malaria); T3.5; Antimalarials, Oregon Health & Science University; Acridones (malaria), Oregon Health & Science University; Endochin-like quinolones, Oregon Health & Science University; Hemozoin formation inhibitors (malaria), Oregon Health & Science University; Modified acridone anti-malaria drugs, DesignMedix/Portland State University; SYNAC series of modified acridones (malaria), DesignMedix/Portland State University; T2 (malaria), Oregon Health & Science University; X5 (malaria), Oregon Health &Science University; T-3.5, DesignMedix/Portland State University
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | ||||||||||||||||||
| Combinatorial Drugs (CBD) | Click to Jump to the Detailed CBD Information of This Drug | ||||||||||||||||||

